Norway Life Science 2025: From Health Data Access to Value and Groundbreaking Research
Can artificial intelligence coupled with health data be the answer to tomorrow's challenges in healthcare, leading to new services and treatments, and make the Norwegian health industry internationally competitive and attractive for significant investments? We summarize the current status and discuss the way forward.
Date:
Place:
Meet Ullevål
Norway Life Science 2025 brings together the country's leading players in health, life sciences, and artificial intelligence to find solutions that ensure Norway reaps greater benefits from its significant investments in health research.
The main themes are health data and artificial intelligence, continuing the topic from 2024.
At the conference, you will hear from the leading research environments in the country, key leaders in Norway's healthcare sector, globally leading pharmaceutical companies, startups, investors, and decision-makers.
Some of the highlights include:
State secretary Torgeir Micaelsen will present the government's ambitions for further investment in health data and Minister of Trade and Industry Cecilie Myrseth will talk about Norwegian policy for the health industry.
We have two international keynote speakers:
- Timothy M. Miller, Vice President of Enterprise Science & Innovation at Thermo Fisher Scientific,
- Erwin Böttinger, Director at the Wyss Centre, and
They will discuss how artificial intelligence coupled with health data can address the major health challenges we face.
Erna Solberg, leader of the Conservative Party of Norway – Høyre, along with leaders from the Norwegian Institute of Public Health, the Directorate of Health, Oslo University Hospital, the pharmaceutical industry, and others will discuss what a targeted investment in health data means for developing a competitive Norwegian health industry and how research and innovation can be tools for developing a world-leading healthcare system.
On day two, we will focus on how we will deliver the healthcare services of tomorrow and how we can enhance Norwegian competitiveness, based on the report on European competitiveness by former European Central Bank President Mario Draghi.
There will be a career event called Young Talents 2024 and a pitch competition for startups and innovation projects.
The conference is an Oslo Science City Arena event in collaboration with leading partners.
The University of Oslo organizes the event together with Oslo Science City, Oslo University Hospital, NMBU – Norwegian University of Life Sciences, SINTEF, Association of the Pharmaceutical Industry in Norway, Oslo Cancer Cluster, The Life Science Cluster, and Norway Health Tech. Industrial partners include AstraZeneca, Bayer, GE Healthcare, GSK, Novartis, Novo Nordisk, Roche, and, Thermo Fisher.